Six Versus Twelve Months Clopidogrel Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup Analysis

In patients presenting with acute coronary syndrome (ACS) the optimal duration of dual-antiplatelet therapy after drug-eluting stent (DES) implantation remains unclear. At 6 months after intervention, patients receiving clopidogrel were randomly assigned to either a further 6-month period of placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lohaus, Raphaela, Michel, Jonathan, Mayer, Katharina, Lahmann, Anna Lena, Byrne, Robert A., Wolk, Annabelle, ten Berg, Jurrien M., Neumann, Franz-Josef, Han, Yaling, Adriaenssens, Tom, Tölg, Ralph, Seyfarth, Melchior, Maeng, Michael, Zrenner, Bernhard, Jacobshagen, Claudius, Wöhrle, Jochen, Kufner, Sebastian, Morath, Tanja, Ibrahim, Tareq, Bernlochner, Isabell, Fischer, Marcus, Schunkert, Heribert, Laugwitz, Karl-Ludwig, Mehilli, Julinda, Kastrati, Adnan, Schulz-Schüpke, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021963/
https://www.ncbi.nlm.nih.gov/pubmed/27624287
http://dx.doi.org/10.1038/srep33054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021963/
https://www.ncbi.nlm.nih.gov/pubmed/27624287
http://dx.doi.org/10.1038/srep33054

Ejemplares similares